Johnson & Johnson Price to Book Ratio 2010-2022 | JNJ
Historical price to book ratio values for Johnson & Johnson (JNJ) over the last 10 years. The current price to book ratio for Johnson & Johnson as of February 03, 2023 is 5.80.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Johnson & Johnson Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2023-02-03 |
164.61 |
|
5.77 |
| 2022-09-30 |
162.32 |
$28.51 |
5.69 |
| 2022-06-30 |
175.20 |
$29.04 |
6.03 |
| 2022-03-31 |
173.83 |
$28.41 |
6.12 |
| 2021-12-31 |
166.70 |
$28.16 |
5.92 |
| 2021-09-30 |
156.34 |
$26.69 |
5.86 |
| 2021-06-30 |
158.53 |
$26.44 |
6.00 |
| 2021-03-31 |
157.18 |
$25.01 |
6.29 |
| 2020-12-31 |
149.58 |
$24.04 |
6.22 |
| 2020-09-30 |
140.51 |
$24.49 |
5.74 |
| 2020-06-30 |
131.85 |
$23.92 |
5.51 |
| 2020-03-31 |
122.09 |
$23.28 |
5.24 |
| 2019-12-31 |
134.94 |
$22.59 |
5.97 |
| 2019-09-30 |
118.86 |
$22.13 |
5.37 |
| 2019-06-30 |
127.95 |
$23.01 |
5.56 |
| 2019-03-31 |
127.55 |
$22.20 |
5.75 |
| 2018-12-31 |
116.98 |
$22.44 |
5.21 |
| 2018-09-30 |
124.45 |
$24.09 |
5.17 |
| 2018-06-30 |
108.57 |
$23.45 |
4.63 |
| 2018-03-31 |
113.82 |
$23.58 |
4.83 |
| 2017-12-31 |
123.31 |
$22.43 |
5.50 |
| 2017-09-30 |
114.05 |
$27.55 |
4.14 |
| 2017-06-30 |
115.31 |
$26.78 |
4.31 |
| 2017-03-31 |
107.85 |
$26.10 |
4.13 |
| 2016-12-31 |
99.12 |
$26.02 |
3.81 |
| 2016-09-30 |
100.93 |
$26.73 |
3.78 |
| 2016-06-30 |
102.95 |
$26.47 |
3.89 |
| 2016-03-31 |
91.19 |
$26.40 |
3.45 |
| 2015-12-31 |
85.95 |
$25.82 |
3.33 |
| 2015-09-30 |
77.54 |
$25.86 |
3.00 |
| 2015-06-30 |
80.33 |
$25.69 |
3.13 |
| 2015-03-31 |
82.31 |
$24.45 |
3.37 |
| 2014-12-31 |
84.97 |
$25.06 |
3.39 |
| 2014-09-30 |
86.05 |
$27.31 |
3.15 |
| 2014-06-30 |
83.89 |
$27.65 |
3.03 |
| 2014-03-31 |
78.22 |
$27.08 |
2.89 |
| 2013-12-31 |
72.41 |
$26.25 |
2.76 |
| 2013-09-30 |
68.07 |
$24.75 |
2.75 |
| 2013-06-30 |
66.92 |
$24.75 |
2.70 |
| 2013-03-31 |
63.06 |
$23.85 |
2.64 |
| 2012-12-31 |
53.79 |
$23.33 |
2.31 |
| 2012-09-30 |
52.42 |
$23.08 |
2.27 |
| 2012-06-30 |
50.93 |
$21.97 |
2.32 |
| 2012-03-31 |
49.25 |
$22.35 |
2.20 |
| 2011-12-31 |
48.54 |
$20.95 |
2.32 |
| 2011-09-30 |
46.70 |
$22.52 |
2.07 |
| 2011-06-30 |
48.35 |
$22.67 |
2.13 |
| 2011-03-31 |
42.70 |
$21.86 |
1.95 |
| 2010-12-31 |
44.17 |
$20.66 |
2.14 |
| 2010-09-30 |
43.87 |
$20.85 |
2.10 |
| 2010-06-30 |
41.43 |
$19.19 |
2.16 |
| 2010-03-31 |
45.32 |
$19.19 |
2.36 |
| 2009-12-31 |
44.43 |
$18.37 |
2.42 |
| 2009-09-30 |
41.67 |
$18.27 |
2.28 |
| 2009-06-30 |
38.56 |
$16.79 |
2.30 |
| 2009-03-31 |
35.40 |
$15.87 |
2.23 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$432.802B |
$94.943B |
|
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|
